Skip to content

Tuesday, September 8, 2026

Latest:

Understanding the underlying mechanism of steroid-resistant asthma
What we take with us: Professional development lessons that last
Making decisions: how the human brain continuously balances competing goals in real time
Dr. Kenneth Liao completes 1,000th robotic heart procedure, advancing the future of cardiac surgery at Baylor
Immune responses to urinary tract infection linked to birth outcomes

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

gilteritinib

Uncovering a new vulnerability in acute myeloid leukemia

August 18, 2026 Acute myeloid leukemia, AML, cancer drug resistance, Ferroptosis, gilteritinib, overcoming cancer treatment resistance, Research, selenoprotein

The team explored the possibility of leveraging the new vulnerability to overcome therapy resistance.

From the Labs: Image of the Month

From the Labs: Tau travels between neurons

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951